Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.
about
Features of the parkin/ariadne-like ubiquitin ligase, HHARI, that regulate its interaction with the ubiquitin-conjugating enzyme, Ubch7Glycine-alanine repeats impair proper substrate unfolding by the proteasomeModulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors.Adoptive T-Cell ImmunotherapyInfectious MononucleosisUnderstanding the interplay between host immunity and Epstein-Barr virus in NPC patientsEffects of messenger RNA structure and other translational control mechanisms on major histocompatibility complex-I mediated antigen presentationTherapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinomaAutophagy in the regulation of pathogen replication and adaptive immunityStructural Insights into the Regulatory Particle of the Proteasome from Methanocaldococcus jannaschiiEpstein-Barr virus latent genesAggresomes: a cellular response to misfolded proteinsVaricella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells.Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens?Disordered proteinaceous machinesRecognition and processing of ubiquitin-protein conjugates by the proteasomeThe ubiquitin-proteasome pathway: on protein death and cell lifeStepwise unfolding of a β barrel protein by the AAA+ ClpXP protease.Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7.Epstein-Barr virus latency switch in human B-cells: a physico-chemical model.T cell detection of a B-cell tropic virus infection: newly-synthesised versus mature viral proteins as antigen sources for CD4 and CD8 epitope display.The synthesis of truncated polypeptides for immune surveillance and viral evasion.The expression of genes coding for distinct types of glycine-rich proteins varies according to the biology of three metastriate ticks, Rhipicephalus (Boophilus) microplus, Rhipicephalus sanguineus and Amblyomma cajennenseInhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells.Learning from the genome sequence of Mycobacterium tuberculosis H37Rv.Human pathogen subversion of antigen presentation.Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism.Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice.Aggresomes and Russell bodies. Symptoms of cellular indigestion?DNA and RNA-based vaccines: principles, progress and prospects.Proteolysis and class I major histocompatibility complex antigen presentation.Repression of Epstein-Barr virus EBNA-1 gene transcription by pRb during restricted latencyEBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.Ubiquitin-mediated proteolysis: biological regulation via destruction.Repeat sequence of Epstein-Barr virus-encoded nuclear antigen 1 protein interrupts proteasome substrate processing.Comparative immune response to PE and PE_PGRS antigens of Mycobacterium tuberculosis.Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis
P2860
Q24291032-249F88D0-717E-4203-B819-44A2A4BFE4FFQ24543904-BB2DE88C-81A7-4418-AD8E-F74D5BE7FE2FQ24811971-B16C116E-50E8-4137-92D1-64B40DB7886FQ26782845-1135D148-B200-4BB6-9956-95B46A4DFC2DQ26783692-F215C3F0-E4B1-4E4C-90D8-61B37EC196DEQ26823898-4540C14C-885D-475C-BFE9-98EA1C11FF64Q26852540-F289E077-502D-40C4-AE62-D2E11CCA918AQ27016002-ADF8C756-3BB3-44E4-9507-804BE475248AQ27023949-B84E8AE3-39C5-4849-ACDC-11D3E0E61071Q27655690-3FEE736A-F1B4-4983-BDB2-4C6D543264BBQ28082701-7FAD3C15-9C7F-446F-B715-BD8DE96A6A61Q28292275-F706D4C6-625A-46A4-9C03-E6C0D2E3F1B5Q28363307-1FBB7F08-03CC-4CC6-B740-D86FACA5290AQ28487130-8CD2EACD-AECA-41EA-B336-62C9CD4679E1Q28652765-88F5F9A7-2309-4181-A331-1EF4345C2569Q29547616-EC066572-E9D0-4091-B001-AA08017DB9A9Q29619270-8F42BE32-EB97-4781-9E38-44D20468B149Q30155499-93A13BC7-9437-4C68-B500-29F555E0CACFQ30305830-FAF670DA-4FDC-4AA5-94CF-6A2066B37147Q30442797-68E93317-6A9D-430E-B90C-8C8C1496C78AQ30941966-79CB22E4-BB2D-4A5C-A349-B8E934A762FFQ33296308-BE70CC5D-6DC9-439F-8E3B-43315B01BE50Q33519520-0C76822E-2928-484E-B4DF-0CEBF5F305A1Q33526302-82F413AC-FE0D-4B8B-B514-C7D5AED0E12AQ33597079-45915EF8-3B59-4872-B52D-AA3A337AAFA4Q33649532-EA0F4749-18DC-4EDB-8823-6BFA308BA9E2Q33650107-EE3DA575-7050-4D17-8FCB-5BE30DDADB60Q33665526-1EA73BB6-51D6-4E76-BCB2-A6F6C64E15ACQ33683402-9AA57D0F-6354-46A0-9E0A-B2541589A8DDQ33733617-A84B104B-6019-4681-A013-8F8DC6FD2F76Q33756914-2E28FB73-7414-4854-92E9-006A89A43FB9Q33757033-CBC9C75E-E1D4-4B10-96C6-BB70ABFE91F1Q33783789-4838E9E2-4A8C-43DD-95AB-DC0A4450D9ABQ33815369-1E922C85-11CC-42BF-AA42-163AEB76F7B9Q33818658-57363F92-50BB-468A-96A6-EB24E8AB87AFQ33860748-896E6911-AD19-43F0-B74C-05AE447DA675Q33910576-E59F47AF-6DB2-42AE-9985-D250F019D9FDQ33974768-7ED40678-527D-43B4-9646-706ACD7615C5Q34008969-96DB5B01-2E28-4E75-B73B-30497051FD98Q34010086-A643916D-5C2D-45C2-A2C2-8CF06C210D0F
P2860
Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Inhibition of ubiquitin/protea ...... -Barr virus nuclear antigen 1.
@en
type
label
Inhibition of ubiquitin/protea ...... -Barr virus nuclear antigen 1.
@en
prefLabel
Inhibition of ubiquitin/protea ...... -Barr virus nuclear antigen 1.
@en
P2093
P2860
P356
P1476
Inhibition of ubiquitin/protea ...... -Barr virus nuclear antigen 1.
@en
P2093
Leonchiks A
Levitskaya J
Masucci MG
P2860
P304
12616-12621
P356
10.1073/PNAS.94.23.12616
P407
P577
1997-11-01T00:00:00Z